Hormone replacement therapy does not affect 24-h ambulatory blood pressure in healthy non-smoking postmenopausal women

Blood Pressure Monitoring

Volumn 8, Issue 2, 2003, Pages 57-61

  Mills, Paul J ^a,c   Farag, Noha H ^a   Matthews, Scott ^a   Nelesen, Richard A ^a   Berry, Charles C ^b   Dimsdale, Joel E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UCSD MEDICAL CENTER   (United States)

Author keywords

Ambulatory blood pressure; Estrogen only replacement therapy; Hormone replacement therapy; Sodium

Indexed keywords

ESTRADIOL; MEDROXYPROGESTERONE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BODY MASS; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HORMONE SUBSTITUTION; HUMAN; NORMAL HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; SODIUM EXCRETION; SODIUM INTAKE; SODIUM URINE LEVEL; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; DRUG THERAPY, COMBINATION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; POSTMENOPAUSE; SMOKING; SODIUM;

EID: 0037974534     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126097-200304000-00001     Document Type: Article

References (31)

1. Blum M, Zacharovitch D, Pery J, Gilerowitch M. Estrogen replacement therapy (ERT) by a special regimen in the years following menopause. Clin Exp Obstet Gynecol 1989; 16(1):9-11.
2. Lip GY, Beevers M, Churchill D, Beevers DG. Hormone replacement therapy and blood pressure in hypertensive women. J Hum Hypertens 1994; 8:491-494.
3. Buller JC, Kritz-Silverstein D, Barrett-Connor E, Wingard D. Type A behavior pattern, heart disease risk factors, and estrogen replacement therapy in postmenopausal women: the Rancho Bernardo Study. J Womens Health 1998; 7:49-56.
4. PEPI Group. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. The Writing Group for the PEPI Trial. JAMA 1995; 273:199-208.
5. Hayward CS, Samaras K, Campbell L, Kelly RP. Effect of combination hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic postmenopausal women. Am J Hypertens 2001; 14:699-703.
6. Akkad AA, Halligan AW, Abrams K, al-Azzawi F. Differing responses in blood pressure over 24 hours in normotensive women receiving oral or transdermal estrogen replacement therapy. Obstet Gynecol 1997; 89:97-103.
7. Manhem K, Ahlm H, Milsom I, Svensson A. Transdermal oestrogen reduces daytime blood pressure in hypertensive women. J Human Hypertens 1998; 12:323-327.
8. Mercuro G, Zoncu S, Piano D, Pilia I, Lao A, Melis GB, Cherchi A. Estradiol-17beta reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension. Am J Hypertens 1998; 11:909-913.
9. van Ittersum FJ, van Baal WM, Kenemans P, Mijatovic V, Donker AJ, van der Mooren MJ, Stehouwer CD. Ambulatory - not office - blood pressures decline during hormone replacement therapy in healthy postmenopausal women. Am J Hypertens 1998; 11:1147-1152.
10. Harvey PJ, Wing LM, Savage J, Molloy D. The effects of different types and doses of oestrogen replacement therapy on clinic and ambulatory blood pressure and the renin-angiotensin system in normotensive postmenopausal women. J Hypertens 1999; 17:405-411.
11. Seely EW, Walsh BW, Gerhard MD, Williams GH. Estradiol with or without progesterone and ambulatory blood pressure in postmenopausal women. Hypertension 1999; 33:1190-1194.
12. Szekacs B, Vajo Z, Acs N, Hada P, Csuzi L, Bezeredi J, et al. Hormone replacement therapy reduces mean 24-hour blood pressure and its variability in postmenopausal women with treated hypertension. Menopause 2000; 7:31-35.
13. Manwaring P, Morfis L, Diamond T, Howes LG. Effects of hormone replacement therapy on ambulatory blood pressure and vascular responses in normotensive women. Blood Press 2000; 9:22-27.
14. Sorensen MB, Rasmussen V, Jensen G, Ottesen B. Temporal changes in clinic and ambulatory blood pressure during cyclic post-menopausal hormone replacement therapy. J Hypertens 2000; 18:1387-1391.
15. Harvey PJ, Molloy D, Upton J, Wing LM. Dose response effect of conjugated equine oestrogen on blood pressure in postmenopausal women with hypertension. Blood Press 2000; 9:275-282.
16. Cacciatore B, Paakkari I, Hasselblatt R, Nieminen MS, Toivonen J, Tikkanen MI, Ylikorkala O. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women. Am J Obstet Gynecol 2001; 184:904-909.
17. Vongpatanasin W, Tuncel M, Mansour Y, Arbique D, Victor RG. Transdermal estrogen replacement therapy decreases sympathetic activity in postmenopausal women. Circulation 2001; 103:2903-2908.
18. Affinito P, Palomba S, Bonifacio M, Fontana D, Izzo R, Trimarco B, Nappi C. Effects of hormonal replacement therapy in postmenopausal hypertensive patients. Maturitas 2001; 40:75-83.
19. Girdler SS, Hinderliter AL, West SG, Grewen K, Steege J, Light KC. Postmenopausal smokers show reduced hemodynamic benefit from oral hormone replacement. Am J Cardiol 2000; 86:590-592.
20. Di Carlo C, Tommaselli GA, Pisano G, Nasti A, Rossi V, Palomba S, Nappi C. Serum leptin levels in postmenopausal women: effects of transdermal hormone replacement therapy. Menopause 2000; 7:36-41.
21. Yamori Y, Liu L, Ikeda K, Mizushima S, Nara Y, Simpson FO, for the WHO Cardiovascular Diseases and Alimentary Comparison (WHO-CARDIAC). Study Different associations of blood pressure with 24-hour urinary sodium excretion among pre- and post-menopausal women. WHO Cardiovascular Diseases and Alimentary Comparison (WHO-CARDIAC) Study. J Hypertens 2001; 19:535-538.
22. Butkevich A, Abraham C, Phillips RA. Hormone replacement therapy and 24-hour blood pressure profile of postmenopausal women. Am J Hypertens 2000; 13:1039-1041.
23. Dimsdale JE, von Kanel R, Profant J, Nelesen R, Ancoli-Israel S, Ziegler M. Reliability of nocturnal brood pressure dipping. Blood Press Monit 2000; 5:217-221.
24. Metropolitan Life Foundation: 1983 Metropolitan height and weight tables. Stat Bull 1983;64:1.
25. Pickering TG, Kario K. Nocturnal non-dipping: what does it augur? Curr Opin Nephrol Hypertens 2001; 10:611-616.
26. Farag NH, Nelesen RA, Parry BL, Loredo JS, Dimsdale JE, Mills PJ. Autonomic and cardiovascular function in post-menopausal women: the effects of estrogen vs. combination Therapy. Am J Obstet Gynecol 2002; 186:954-961.
27. Mahon SM, Williams M. Information needs regarding menopause. Cancer Nurs 2000; 23(3):176-185.
28. Santoro NF, Col NF, Eckman MH, Wong JB, Pauker SG, Cauley JA, et al. Therapeutic controversy: hormone replacement therapy - where are we going? J Clin Endocrinol Metab 1999; 84:1798-1812.
29. Freeman R. Hormone replacement therapy (estrogen and progesterone): is it necessary for heart disease prevention? Prev Cardiol 2000; 3:21-23.
30. Barrett-Connor E, Grady D, Sashegyi A, Anderson PW, Cox DA, Hoszowski K, et al. Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA 2002; 287:847-857.
31. Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288:321-333.